|
Market Closed -
Euronext Paris
16:55:00 13/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.0510 EUR | -3.41% |
|
-6.25% | +0.39% |
| 10-30 | Neolife SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 03-30 | Neolife SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Company Valuation: Neolife
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Market Cap 1 | 6.866 | 23.36 | 16.13 | 3.687 | 6.929 |
| Change | - | 240.27% | -30.95% | -77.14% | 87.91% |
| Enterprise Value (EV) 1 | 7.143 | 23.31 | 17 | 4.341 | 7.35 |
| Change | - | 226.3% | -27.07% | -74.46% | 69.33% |
| P/E | -8.1x | -45.2x | -95.3x | -1.87x | -13.2x |
| PBR | 3.27x | 10.9x | 7.24x | 1.41x | 1.61x |
| PEG | - | 0.9x | 1.4x | -0x | 0.2x |
| Capitalization / Revenue | 0.79x | 2.88x | 1.46x | 0.27x | 0.52x |
| EV / Revenue | 0.83x | 2.87x | 1.53x | 0.32x | 0.55x |
| EV / EBITDA | -15.6x | 68.8x | 118x | -4.85x | 49.3x |
| EV / EBIT | -11.3x | -68.3x | 1,953x | -4.21x | -13.9x |
| EV / FCF | -18.3x | 55.1x | -15.6x | -7.71x | - |
| FCF Yield | -5.47% | 1.82% | -6.41% | -13% | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.02 | -0.01 | -0.003233 | -0.0376 | -0.005432 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 8.655 | 8.126 | 11.09 | 13.55 | 13.43 |
| EBITDA 1 | -0.4572 | 0.3389 | 0.1444 | -0.8945 | 0.1491 |
| EBIT 1 | -0.6331 | -0.3414 | 0.008702 | -1.03 | -0.5289 |
| Net income 1 | -0.9307 | -0.5163 | -0.1693 | -3.625 | -0.5235 |
| Net Debt 1 | 0.2768 | -0.0553 | 0.8645 | 0.6534 | 0.4211 |
| Reference price 2 | 0.1620 | 0.4520 | 0.3080 | 0.0704 | 0.0719 |
| Nbr of stocks (in thousands) | 42,382 | 51,687 | 52,378 | 52,378 | 96,371 |
| Announcement Date | 25/06/20 | 05/04/22 | 05/04/22 | 28/04/23 | 29/04/24 |
1EUR in Million2EUR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 5.42M | ||
| 18.78x | 2.08x | 10.39x | 1.65% | 61.97B | ||
| 20.61x | 2.76x | 10.9x | 2.52% | 49.2B | ||
| 37.24x | 3.66x | 19.48x | 1.04% | 37.75B | ||
| 40.72x | 6.25x | 19.54x | 0.66% | 36.53B | ||
| 32.21x | 4.95x | 16.57x | 0.73% | 35.76B | ||
| 13.81x | 1.64x | 7.62x | 2.2% | 34.29B | ||
| 18.17x | 2.08x | 8.56x | 1.16% | 21.9B | ||
| 69.99x | 4.31x | 69.23x | 0.33% | 21.82B | ||
| 17.55x | 4.73x | 9.3x | 4.27% | 18.3B | ||
| Average | 29.90x | 3.61x | 19.07x | 1.62% | 32B | |
| Weighted average by Cap. | 28.16x | 3.43x | 16.86x | 1.58% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALNLF Stock
- Valuation Neolife
Select your edition
All financial news and data tailored to specific country editions
















